We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
AstraZeneca has submitted an sNDA for Nexium IV to treat patients with peptic ulcer bleeding after endoscopy. If approved, Nexium IV would be the first proton pump inhibitor therapy for this indication, according to AstraZeneca.